Edinburgh Research Archive

Paediatric Schistosomiasis: diagnosis, morbidity and treatment

dc.contributor.advisor
Mutapi, Francisca
en
dc.contributor.advisor
Woolhouse, Mark
en
dc.contributor.author
Wami, Welcome Mkululi
en
dc.contributor.sponsor
Wellcome Trust
en
dc.date.accessioned
2016-03-04T15:30:49Z
dc.date.available
2016-03-04T15:30:49Z
dc.date.issued
2015-11-26
dc.description.abstract
Schistosomiasis is a major parasitic disease caused by parasitic helminths of the genus Schistosoma which affects children in Africa, with negative impacts on general health, growth and cognitive development. Infection and morbidity are controlled by treatment with the antihelminthic drug praziquantel. Preschool children (aged ≤5 years old) have been neglected both in terms of research and control, and it is only recently that the World Health Organization (WHO) recommended praziquantel treatment and the inclusion of preschool children in control programmes. However, the burden of disease in this age group still remains poorly understood, and the performance of the currently available tools for detecting infection and morbidity is still yet to be systematically evaluated. The aim of this thesis was to compare the utility of currently available tools for diagnosing S. haematobium infection and related morbidity. The initial study cohort consisted of 438 Zimbabwean children (age range: 1-10 years) who were endemically exposed. Point-of-care schistosome-related morbidity markers applicable in the field, as well as serological biomarkers (CHI3L1, CRP, ferritin, resistin and SLPI) and inflammatory cytokines (IL-4, IL-5, IL-10, IL-13 and IFN-γ) that could predict early stages of immune-mediated pathology due to schistosomiasis were measured. Using a combination of applied statistical methods, the effect of treatment on factors associated with S. haematobium exposure, infection and morbidity in children aged 1-5 years was determined and the findings compared with those observed in children aged between 6-10 years old, who are the current targets of the schistosome control programmes. In this thesis, I able to demonstrate that preschool children carried significant infection, further reiterating the need for their inclusion in control programmes. Furthermore, this study demonstrated the importance of using additional sensitive diagnostic methods as this has implications on the required intervention strategies for the targeted populations. This study further revealed that preschool children can be effectively screened for schistosome-related morbidity using the same currently available diagnostic tools applicable to older children. Urinalysis markers microhaematuria, proteinuria and albuminuria are recommended in this thesis as the best choice for rapid assessment of morbidity attributed to S. haematobium infection in the field. Additionally, it was shown that the praziquantel treatment regimens aimed at controlling schistosome infection and morbidity currently designated for primary school-aged children and older populations are applicable to preschool-aged children. The involvement of serum biomarkers and immune correlates in the biological processes of inflammation suggests that these markers can be potential early predictors of schistosome-related pathology. Further research efforts are required to establish the relationship between these biomarkers and presence of schistosome-related morbidity as measured using point-of-care indicators in larger cohorts of populations chronically exposed to schistosome infections. In summary, the findings of this thesis highlight the need for the refinement of existing diagnostic methods for accurate detection of infection and morbidity in children. This will enable appropriate and timely intervention strategies, aimed at improving the current and future health of preschool aged-children to be implemented. The findings presented here will aid researchers and other stakeholders in making informed choices about intervention tools for control programmes targeting young children.
en
dc.identifier.uri
http://hdl.handle.net/1842/15674
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Wami, W. M., Nausch, N., Bauer, K., Midzi, N., Gwisai, R., Simmonds, P., Mduluza, T., Woolhouse, M. & Mutapi, F. (2014). Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes. Parasitology, 141, 1962-1970.
en
dc.relation.hasversion
Wami, W. M., Nausch, N., Midzi, N. & Gwisai, R. (2015). Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children. PLoS Neglected Tropical Diseases, 9 (3), e0003649.
en
dc.rights
Attribution-NonCommercial-ShareAlike 4.0 International
en
dc.rights.uri
http://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subject
Schistosomiasis
en
dc.subject
children
en
dc.subject
pre-school
en
dc.subject
morbidity
en
dc.title
Paediatric Schistosomiasis: diagnosis, morbidity and treatment
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Doctoral
en
dc.type.qualificationname
PhD Doctor of Philosophy
en

Files

Original bundle

Now showing 1 - 1 of 1
Name:
Wami2015.pdf
Size:
13.89 MB
Format:
Adobe Portable Document Format

This item appears in the following Collection(s)